共 85 条
Cysteine Peptidase Cathepsin X as a Therapeutic Target for Simultaneous TLR3/4-mediated Microglia Activation
被引:9
作者:
Pislar, Anja
[1
]
Nedeljkovic, Biljana Bozic
[2
]
Peric, Mina
[2
]
Jakos, Tanja
[1
]
Zidar, Nace
[3
]
Kos, Janko
[1
,4
]
机构:
[1] Univ Ljubljana, Fac Pharm, Dept Pharmaceut Biol, Askerceva 7, Ljubljana 1000, Slovenia
[2] Univ Belgrade, Fac Biol, Inst Physiol & Biochem, Studentski Trg 16, Belgrade 11000, Serbia
[3] Univ Ljubljana, Fac Pharm, Dept Pharmaceut Chem, Askerceva 7, Ljubljana 1000, Slovenia
[4] Jozef Stefan Inst, Dept Biotechnol, Jamova Cesta 39, Ljubljana 1000, Slovenia
关键词:
Microglia;
Toll-like receptors;
Cathepsin X;
Proinflammatory mediators;
Neuroinflammation;
Neuroprotection;
NF-KAPPA-B;
CENTRAL-NERVOUS-SYSTEM;
DOUBLE-STRANDED-RNA;
TOLL-LIKE RECEPTORS;
NITRIC-OXIDE;
DENDRITIC CELLS;
DIFFERENTIAL EXPRESSION;
ALZHEIMERS-DISEASE;
IMMUNE-RESPONSES;
INNATE IMMUNITY;
D O I:
10.1007/s12035-021-02694-2
中图分类号:
Q189 [神经科学];
学科分类号:
071006 ;
摘要:
Microglia are resident macrophages in the central nervous system that are involved in immune responses driven by Toll-like receptors (TLRs). Microglia-mediated inflammation can lead to central nervous system disorders, and more than one TLR might be involved in these pathological processes. The cysteine peptidase cathepsin X has been recognized as a pathogenic factor for inflammation-induced neurodegeneration. Here, we hypothesized that simultaneous TLR3 and TLR4 activation induces synergized microglia responses and that these phenotype changes affect cathepsin X expression and activity. Murine microglia BV2 cells and primary murine microglia were exposed to the TLR3 ligand polyinosinic-polycytidylic acid (poly(I:C)) and the TLR4 ligand lipopolysaccharide (LPS), individually and simultaneously. TLR3 and TLR4 co-activation resulted in increased inflammatory responses compared to individual TLR activation, where poly(I:C) and LPS induced distinct patterns of proinflammatory factors together with different patterns of cathepsin X expression and activity. TLR co-activation decreased intracellular cathepsin X activity and increased cathepsin X localization at the plasma membrane with concomitant increased extracellular cathepsin X protein levels and activity. Inhibition of cathepsin X in BV2 cells by AMS36, cathepsin X inhibitor, significantly reduced the poly(I:C)- and LPS-induced production of proinflammatory cytokines as well as apoptosis. Additionally, inhibiting the TLR3 and TLR4 common signaling pathway, PI3K, with LY294002 reduced the inflammatory responses of the poly(I:C)- and LPS-activated microglia and recovered cathepsin X activity. We here provide evidence that microglial cathepsin X strengthens microglia activation and leads to subsequent inflammation-induced neurodegeneration. As such, cathepsin X represents a therapeutic target for treating neurodegenerative diseases related to excess inflammation.
引用
收藏
页码:2258 / 2276
页数:19
相关论文